These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31704366)

  • 41. Unique characteristics of
    Kim YS; Jeong H; Choi JW; Oh HE; Lee JH
    Saudi J Gastroenterol; 2017; 23(5):268-274. PubMed ID: 28937020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
    Mehrvarz Sarshekeh A; Alshenaifi J; Roszik J; Manyam GC; Advani SM; Katkhuda R; Verma A; Lam M; Willis J; Shen JP; Morris J; Davis JS; Loree JM; Lee HM; Ajani JA; Maru DM; Overman MJ; Kopetz S
    Clin Cancer Res; 2021 Mar; 27(6):1663-1670. PubMed ID: 33414133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic alterations in gastric cancer patients according to sex.
    Hsu LW; Huang KH; Chen MH; Fang WL; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
    Aging (Albany NY); 2020 Dec; 13(1):376-388. PubMed ID: 33288737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer.
    Kim JY; Park CK; Noh S; Cheong JH; Noh SH; Kim H
    Gut Liver; 2023 Sep; 17(5):753-765. PubMed ID: 36789575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
    Böger C; Behrens HM; Mathiak M; Krüger S; Kalthoff H; Röcken C
    Oncotarget; 2016 Apr; 7(17):24269-83. PubMed ID: 27009855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.
    Sun M; Gu Y; Fang H; Shao F; Lin C; Zhang H; Li H; He H; Li R; Wang J; Liu H; Xu J
    Cancer Sci; 2024 Mar; 115(3):905-915. PubMed ID: 38148578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.
    Kim DH; Bae GE; Suh KS; Ryuman D; Song KS; Kim JS; Lee SI; Yeo MK
    In Vivo; 2020; 34(6):3171-3180. PubMed ID: 33144421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
    Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
    Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deletion in HSP110 T
    Kim KJ; Lee TH; Kim JH; Cho NY; Kim WH; Kang GH
    Hum Pathol; 2017 Sep; 67():109-118. PubMed ID: 28811251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MET is overexpressed in microsatellite instability-high gastric carcinoma.
    Sim J; Heo YJ; Bae H; Shin HC; Kim B; Cho J; Kim ST; Lee J; Kang WK; Kim KM
    Pathol Res Pract; 2019 Mar; 215(3):433-438. PubMed ID: 30455128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
    Hissong E; Ramrattan G; Zhang P; Zhou XK; Young G; Klimstra DS; Shia J; Fernandes H; Yantiss RK
    Am J Surg Pathol; 2018 Apr; 42(4):453-462. PubMed ID: 29438172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
    Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
    Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
    Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
    Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer.
    Zhu YP; Sheng LL; Wu J; Yang M; Cheng XF; Wu NN; Ye XB; Cai J; Wang L; Shen Q; Wu JQ
    Hum Pathol; 2018 Aug; 78():28-35. PubMed ID: 29689245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.
    Wang X; Che K; Shi T; Liu Q; Xu X; Wu H; Yu L; Liu B; Wei J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1583-1595. PubMed ID: 35294647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group.
    Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim HK; Shin BK; Kim BH
    Oncotarget; 2016 Dec; 7(49):80426-80434. PubMed ID: 27741514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Li L; Li M; Jiang Z; Wang X
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.
    Zhou Z; Huang D; Yang S; Liang J; Wang X; Rao Q
    Pathol Oncol Res; 2022; 28():1610479. PubMed ID: 35928964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.